Skip to main content

Low-Renin Hypertension

  • Chapter
  • First Online:
  • 761 Accesses

Abstract

Low-renin hypertension is a condition that relates to the sodium status, but a similar situation is present in approximately 25 % of individuals with essential hypertension, without having high aldosterone levels. Indeed, the aldosterone–renin ratio may be raised, and among these individuals some suffer from primary aldosteronism. Thus, there is an overlap between essential hypertension, low-renin hypertension, and primary aldosteronism, indicating that similar treatment regimes may be successful.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Mackenzie IS, Brown MJ (2009) Molecular and clinical investigations in patients with low-renin hypertension. Clin Exp Nephrol 13(1):1–8, Epub 2008/08/16

    Article  PubMed  CAS  Google Scholar 

  2. Gunnells JC Jr, McGuffin WL Jr (1975) Low renin hypertension. Annu Rev Med 26:259–275, Epub 1975/01/11

    Article  PubMed  CAS  Google Scholar 

  3. Mulatero P, Verhovez A, Morello F, Veglio F (2007) Diagnosis and treatment of low-renin hypertension. Clin Endocrinol (Oxf) 67(3):324–334, Epub 2007/06/19

    Article  CAS  Google Scholar 

  4. Adlin EV, Braitman LE, Vasan RS (2013) Bimodal aldosterone distribution in Low-renin hypertension. Am J Hypertens 26(9):1076–1085, Epub 2013/06/13

    Article  PubMed  CAS  Google Scholar 

  5. Cusano NE, Silverberg SJ, Bilezikian JP (2013) Normocalcemic primary hyperparathyroidism. J Clin Densitom 16(1):33–39, Epub 2013/02/05

    Article  PubMed Central  PubMed  Google Scholar 

  6. Gomez-Sanchez CE (1982) The role of steroids in human essential hypertension. Biochem Pharmacol 31(6):893–897, Epub 1982/03/15

    Article  PubMed  CAS  Google Scholar 

  7. Epstein MT, Espiner EA, Donald RA, Hughes H (1977) Effect of eating liquorice on the renin-angiotensin aldosterone axis in normal subjects. Br Med J 1(6059):488–490, Epub 1977/02/19

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  8. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L et al (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89(3):1045–1050, Epub 2004/03/06

    Article  PubMed  CAS  Google Scholar 

  9. Ori Y, Chagnac A, Korzets A, Zingerman B, Herman-Edelstein M, Bergman M et al (2013) Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone. Nephrol Dial Transplant 28(7):1787–93, Epub 2013/02/05

    Article  PubMed  CAS  Google Scholar 

  10. Funder JW (2013) Primary aldosteronism and low-renin hypertension: a continuum? Nephrol Dial Transplant 28(7):1625–7, Epub 2013/03/29

    Article  PubMed  Google Scholar 

  11. Tsukada K, Ishimitsu T, Teranishi M, Saitoh M, Yoshii M, Inada H et al (2002) Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension. J Hum Hypertens 16(11):789–793, Epub 2002/11/22

    Article  PubMed  CAS  Google Scholar 

  12. Nicod J, Bruhin D, Auer L, Vogt B, Frey FJ, Ferrari P (2003) A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients. J Clin Endocrinol Metab 88(6):2495–2500, Epub 2003/06/06

    Article  PubMed  CAS  Google Scholar 

  13. Russo P, Loguercio M, Lauria F, Barba G, Arnout J, Cappuccio FP et al (2007) Age- and gender-dependent association of the -344C/T polymorphism of CYP11B2 with blood pressure in European populations. J Hum Hypertens 21(4):333–336, Epub 2007/02/03

    PubMed  CAS  Google Scholar 

  14. Li W, Liu C (2012) The -344C/T polymorphism in the CYP11B2 gene is associated with essential hypertension in the Chinese. J Renin Angiotensin Aldosterone Syst. Epub 2012/12/04

    Google Scholar 

  15. Tanahashi H, Mune T, Takahashi Y, Isaji M, Suwa T, Morita H et al (2005) Association of Lys173Arg polymorphism with CYP11B2 expression in normal adrenal glands and aldosterone-producing adenomas. J Clin Endocrinol Metab 90(11):6226–6231, Epub 2005/08/25

    Article  PubMed  CAS  Google Scholar 

  16. Li NF, Li HJ, Zhang DL, Zhang JH, Yao XG, Wang HM et al (2013) Genetic variations in the KCNJ5 gene in primary aldosteronism patients from Xinjiang, China. PLoS One 8(1):e54051, Epub 2013/02/06

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  17. Fischer E, Reuschl S, Quinkler M, Rump LC, Hahner S, Bidlingmaier M et al (2013) Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn’s registry. Horm Metab Res 45(7):526–531, Epub 2013/04/25

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Per Hellman M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hellman, P., Hagström, E. (2014). Low-Renin Hypertension. In: Hellman, P. (eds) Primary Aldosteronism. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0509-6_3

Download citation

Publish with us

Policies and ethics